re:"If float is low and no dilution PPS more than likely increases!"
imo, that statement doesn't really make sense.
as i've said twice already: yes, low float gives a bit of boost to momo runs.
but, imo, people won't pay $5 for OPHID unless Kenactiv financials and tangible potential growth merit a $250m market cap, via traditional market evaluations for profitable companies.
specifically, for clarity:
if Kenactiv currently has annual net profits, and strong growth over last 2-3 years, i would consider trades based on a 15-20 P/E ratio.
if Kenactiv currently has annual net profits, and moderate growth over last 2-3 years, i would consider trades based on a 10-15 P/E ratio.
if Kenactiv currently has annual net profits, and no significant growth over last 2-3 years, i would consider trades based on a 8 P/E ratio.
if Kenactiv currently has annual net loss, and moderate growth over last 2-3 years, i would consider trades based on a 0.5-1.0 P/S ratios. (depending entirely on my perception of their growth increasing over next 2 years.)
if Kenactiv starts diluting, all bets are off.
re: Asher not being the reason OPHI dumped, if you have been following the chart since last summer, you might have noticed that there were a few days of massive volume sell-off in concentrated spurts, not aligning with any negative PRs or release of public info.
i've been in a few toxic debt spiral scenarios over the last 15 years and recognize the pattern.
your logic, approach, and math for all of the above likely varies.
so we can agree to disagree.